RecruitingNot ApplicableNCT06091527

Treating Major Depression With Yoga Mono-therapy

Treating Major Depression With Yoga Mono-therapy: 12-Week Randomized Controlled Trial

Sponsor

University of California, San Francisco

Enrollment

180 participants

Start Date

Oct 25, 2024

Study Type

INTERVENTIONAL

Conditions

Depression Mild Depression Moderate

Summary

The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is exploring whether yoga alone — without any medication or talk therapy — can effectively treat major depression. Researchers want to understand if yoga can be a standalone treatment option for people living with depression. **You may be eligible if...** - You are 18 years of age or older - You have been diagnosed with clinical depression - You speak English - You are able to give informed consent to participate **You may NOT be eligible if...** - You are currently taking antidepressant medication - You are currently attending psychotherapy or counseling - You are pregnant - You have significant medical issues that would prevent you from practicing yoga Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.